SEARCH

SEARCH BY CITATION

References

  • Balerio G. N., Aso E. and Maldonado R. (2005) Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl). 181, 260269.
  • Berrendero F., Kieffer B. L. and Maldonado R. (2002) Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J. Neurosci. 22, 1093510940.
  • Berrendero F., Mendizábal V., Robledo P., Galeote L., Bilkei-Gorzo A., Zimmer A. and Maldonado R. (2005) Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J. Neurosci. 25, 11031112.
  • Berrino L., Oliva P., Massimo F., Aurilio C., Maione S., Grella A. and Rossi F. (2003) Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test. Eur. J. Pain. 7, 131137.
  • Bhargava H. N., Gulati A. and Ramarao P. (1989) Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord. J. Pharmacol. Exp. Ther. 251, 2126.
  • Biala G. and Weglinska B. (2006) On the mechanism of cross-tolerance between morphine- and nicotine-induced antinociception: involvement of calcium channels. Prog. Neuropsychopharmacol. Biol. Psychiatry 30, 1521.
  • Briggs C. A. and McKenna D. G. (1996) Effect of MK-801 at the human alpha 7 nicotinic acetylcholine receptor. Neuropharmacology 35, 407414.
  • Cassels B. K., Bermúdez I., Dajas F., Abin-Carriquiry J. A. and Wonnacott S. (2005) From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research. Drug Discov. Today 10, 16571665.
  • Damaj M. I. (2005) Calcium-acting drugs modulate expression and development of chronic tolerance to nicotine-induced antinociception in mice. J. Pharmacol. Exp. Ther. 315, 959964.
  • Damaj M. I. (2007) Nicotinic regulation of calcium/calmodulin-dependent protein kinase II activation in the spinal cord. J. Pharmacol. Exp. Ther. 320, 244249.
  • Damaj M. I. and Martin B. R. (1996) Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice. Eur. J. Pharmacol. 300, 5157.
  • Galeote L., Kieffer B. L., Maldonado R. and Berrendero F. (2006) Mu-opioid receptors are involved in the tolerance to nicotine antinociception. J. Neurochem. 97, 416423.
  • Gardell L. R., Burgess S. E., Dogrul A., Ossipov M. H., Malan T. P., Lai J. and Porreca F. (2002) Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance. Pain 98, 7988.
  • Ghozland S., Matthes H. W., Simonin F., Filliol D., Kieffer B. L. and Maldonado R. (2002) Motivational effects of cannabinoids are mediated by μ-Opioid and κ-Opioid receptors. J. Neurosci. 22, 11461154.
  • Goldstein A., Tachibana S., Lowney L. I., Hunkapiller M. and Hood L. (1979) Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl Acad. Sci. USA 76, 66666670.
  • Gotti C., Zoli M. and Clementi F. (2006) Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol. Sci. 27, 482491.
  • Grabus S. D., Martin B. R., Batman A. M., Tyndale R. F., Sellers E. and Damaj M. I. (2005) Nicotine physical dependence and tolerance in the mouse following chronic oral administration. Psychopharmacology 178, 183192.
  • Hahn B., Stolerman I. P. and Shoaib M. (2000) Kappa-opioid receptor modulation of nicotine-induced behaviour. Neuropharmacology 39, 28482855.
  • Ise Y., Narita M., Nagase H. and Suzuki T. (2002) Modulation of kappa-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Neurosci. Lett. 323, 164166.
  • Juni A., Klein G. and Kest B. (2006) Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems. Brain Res. 1070, 3544.
  • Khotib J., Narita M., Suzuki M., Yajima Y. and Suzuki T. (2004) Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors. Neuropharmacology 46, 531540.
  • Kitchen I., Slowe S. J., Matthes H. W. and Kieffer B. (1997) Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. Brain Res. 778, 7388.
  • Laughlin T. M., Larson A. A. and Wilcox G. L. (2001) Mechanisms of induction of persistent nociception by dynorphin. J. Pharmacol. Exp. Ther. 299, 611.
  • Le Novère N., Corringer P. J. and Changeux J. P. (2002) The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J. Neurobiol. 53, 447456.
  • Malan T. P., Ossipov M. H., Gardell L. R., Ibrahim M., Bian D., Lai J. and Porreca F. (2000) Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain 86, 185194.
  • Mansour A., Fox C. A., Akil H. and Watson S. J. (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 2229.
  • Marco E. M., Llorente R., Perez-Alvarez L., Moreno E., Guaza C. and Viveros M. P. (2005) The kappa-opioid receptor is involved in the stimulating effect of nicotine on adrenocortical activity but not in nicotine induced anxiety. Behav. Brain Res. 163, 212218.
  • Martin M., Matifas A., Maldonado R. and Kieffer B. L. (2003) Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones. Eur. J. Neurosci. 17, 701708.
  • Matthes H. W., Maldonado R., Simonin F. et al. (1996) Loss of morphine induced-analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383, 819823.
  • Mendizabal V., Zimmer A. and Maldonado R. (2006) Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice. Neuropsychopharmacology 31, 19571966.
  • Molander C., Xu Q. and Grant G. (1984) The cytoarchitectonic organization of the spinal cord in the rat. I. The lower thoracic and lumbosacral cord. J. Comp. Neurol. 230, 133141.
  • Narita M., Khotib J., Suzuki M., Ozaki S., Yajima Y. and Suzuki T. (2003a) Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception. J. Neurochem. 85, 11711179.
  • Narita M., Khotib J., Mizoguchi H., Suzuki M., Ozaki S., Yajima Y., Tseng L. F. and Suzuki T. (2003b) Direct evidence for the up-regulation of spinal mu-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse. Eur. J. Neurosci. 18, 24982504.
  • Oka K., Andoh T., Watanabe I., Kamiya Y. and Ito H. (1998) Inhibition of the neuronal nicotinic receptor-mediated current by kappa opioid receptor agonists in PC12 cells. Pflugers Arch. 436, 887893.
  • Ossipov M. H., Kovelowski C. J., Wheeler-Aceto H., Cowan A., Hunter J. C., Lai J., Malan T. P. and Porreca F. (1996) Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone. J. Pharmacol. Exp. Ther. 277, 784788.
  • Paxinos G. and Franklin K. B. J. (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego.
  • Quick M. W. and Lester R. A. (2002) Desensitization of neuronal nicotinic receptors. J. Neurobiol. 53, 457478.
  • Roberts A. J., McDonal J. S., Heyser C. J., Kieffer B. L., Matthes H. W., Koob G. F. and Gold L. H. (2000) μ-Opioid receptor knockout mice do not self-administer alcohol. J. Pharmacol. Exp. Ther. 293, 10021008.
  • Robinson S. E., Vann R. E., Britton A. F., O’connell M. M., James J. R. and Rosecran J. A. (2007) Cellular nicotinic receptor desensitization correlates with nicotine-induced acute behavioral tolerance in rats. Psychopharmacology (Berl) 192, 7178.
  • Simonin F., Valverde O., Smadja C., Slowe S., Kitchen I., Dierich A., Le Meur M., Roques B. P., Maldonado R. and Kieffer B. L. (1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J. 17, 886897.
  • Suh H. W., Song D. K., Choi S. R., Chung K. M. and Kim Y. H. (1996) Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse. Neuropeptides 30, 479484.
  • Tang Y., Zou H., Strong J. A., Cui Y., Xie Q., Zhao G., Jin M. and Yu L. (2006) Paradoxical effects of very low dose MK-801. Eur. J. Pharmacol. 537, 7784.
  • Trujillo K. A. and Akil H. (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251, 8587.
  • Unterwald E. M., Rubenfeld J. M. and Kreek M. J. (1994) Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport 5, 16131616.
  • Vanderah T. W., Gardell L. R., Burgess S. E. et al. (2000) Dynorphin Promotes Abnormal Pain and Spinal Opioid Antinociceptive Tolerance. J.Neurosci. 20, 70747079.
  • Vanderah T. W., Ossipov M. H., Lai J., Malan T. P. and Porreca F. (2001) Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain 92, 59.
  • Vincler M. (2005) Neuronal nicotinic receptors as targets for novel analgesics. Expert. Opin. Investig. Drugs 14, 11911198.
  • Wewers M. E., Dhatt R. K., Snively T. A. and Tejwani G. A. (1999) The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkephalin levels in rats. Brain Res. 822, 107113.
  • Xu M., Petraschka M., McLaughlin J. P., Westenbroek R. E., Caron M. G., Lefkowitz R. J., Czyzyk T. A., Pintar J. E., Terman G. W. and Chavkin C. (2004) Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J. Neurosci. 24, 45764584.
  • Zakharova E. S., Danysz W. and Bespalov A. Y. (2005) Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats. Psychopharmacology (Berl). 179, 128135.
  • Zarrindast M. R., Khoshayand M. R. and Shafaghi B. (1999) The development of cross-tolerance between morphine and nicotine in mice. Eur. Neuropsychopharmacol. 9, 227233.